Reversal of Autism Symptoms among Dizygotic Twins through a Personalized Lifestyle and Environmental Modification Approach: A Case Report and Review of the Literature Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

March 18, 2025

  • Autism spectrum disorder (ASD)
    Autism spectrum disorder (ASD)

    Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social, communication, and behavioral challenges. It involves genetic and environmental factors, including microbiome imbalances which influence symptom severity and overall health.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Last Updated: 2025-01-16

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was studied?

The study focused on the reversal of autism spectrum disorder (ASD) symptoms among dizygotic female twins through a personalized, multidisciplinary therapeutic approach, including microbiome-targeted interventions (MBTIs). The approach primarily targeted modifiable lifestyle and environmental factors believed to contribute to the condition. Following the reversal of autism symptoms in twins, the case report aimed to document the twins’ improvements and review the related literature on environmental and lifestyle influences on ASD.  

Who was studied?

The subjects of the study were dizygotic (fraternal) female twin toddlers who were diagnosed with Level 3 severity ASD, which requires very substantial support. The diagnosis was made when the twins were approximately 20 months old. The case report included detailed documentation of the twins’ medical history, diagnostic evaluations, and therapeutic interventions over a two-year period.  

What were the most important findings of this case study?

Reversal of Autism Symptoms: Both twins exhibited dramatic improvements in their ASD symptoms, as evidenced by significant reductions in their Autism Treatment Evaluation Checklist (ATEC) scores. One twin’s ATEC score decreased from 76 to 32, while the other’s decreased from 43 to 4.

Sustained Improvement: The improvements in the twins’ symptoms remained relatively stable for six months following the last assessment.

Multidisciplinary Approach: The therapeutic interventions involved a variety of licensed clinicians and focused on environmental and lifestyle modifications tailored to each twin’s symptoms, lab results, and other outcome measures. Interventions included dietary changes, nutritional supplements, physical therapies, and environmental modifications.

Parental Involvement: The parents played a crucial role in implementing and achieving the interventions, demonstrating exceptional motivation, compliance, and communication with practitioners.

What are the greatest implications of this case study?

Potential for ASD Reversal: The case report provides encouraging evidence that ASD symptoms can be significantly improved and potentially reversed through a comprehensive, personalized approach that targets modifiable environmental and lifestyle factors.

Role of Environmental and Lifestyle Factors: The findings highlight the significant impact that environmental and lifestyle factors can have on ASD, suggesting that these factors may play a more substantial role than genetic factors in some cases.

Need for Personalized Medicine: The success of the personalized, multidisciplinary approach underscores the importance of individualized treatment plans that consider the unique needs and risk factors of each patient.

Challenges: While the results are promising, the comprehensive and resource-intensive nature of the interventions may not be easily generalizable to all families due to financial and accessibility constraints. This highlights the need for more accessible and cost-effective treatment options.

Future Research: The study calls for prospective studies to further investigate the effectiveness of personalized, multi-modality treatment approaches in reversing ASD symptoms and to establish more precise estimates of the contributions of genetic versus environmental factors in ASD etiology.

Autism spectrum disorder (ASD)

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social, communication, and behavioral challenges. It involves genetic and environmental factors, including microbiome imbalances which influence symptom severity and overall health.

Microbiome-Targeted Interventions (MBTIs)

Microbiome Targeted Interventions (MBTIs) are cutting-edge treatments that utilize information from Microbiome Signatures to modulate the microbiome, revolutionizing medicine with unparalleled precision and impact.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.